Ai helps identify critical interactions for SARS-CoV-2 spike protein binding to ACE2

NewsGuard 100/100 Score

The COVID-19 pandemic remains a major global crisis that has led to extensive adverse health and socioeconomic impacts. Although SARS-CoV-1, SARS-CoV-2, and MERS-CoV viruses belong to the betacoronavirus genus, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seems to have a greater transmission rate compared to previous outbreaks of betacoronaviruses. SARS-CoV-2 spread rapidly to almost all countries worldwide, with continued transmission promoted by new variants of the virus.

Given the emergence of the UK, South African, and South American variants of SARS-CoV-2 and the likelihood of further mutations, there is a compelling need to develop efficient strategies to prevent and manage such outbreaks. A thorough understanding of the mechanism of SARS-CoV-2 infection starting with the virus-host cell interaction is crucial to develop these prevention strategies. Previous studies have shown that several molecular-level factors contribute to increased SARS-CoV-2 infectivity compared to that of SARS-CoV-1.

Based on high-resolution structures, these coronaviruses use a similar mechanism for entry into the host cell, and the initial infection is very much dependent on host cell recognition. This is mediated by the viral S (spike) protein with the help of the human angiotensin-converting enzyme 2 (ACE2). While the ACE2 is a cell surface protein present in various tissues, the spike protein is a homotrimeric type I fusion glycoprotein that protrudes from the viral surface and has two subunits, S1 and S2. Since this spike protein-ACE2 (protein-protein) interaction helps initiate infection, the viral spike protein is a very important therapeutic target.

Comparing the relative dynamics between the SARS-CoV RBD-ACE2 and SARS-CoV-2 RBD-ACE2 complexes

Recently, researchers from the US employed multiple-µs molecular dynamic simulations to compare the relative dynamics, stabilities, and energy differences between the SARS-CoV receptor-binding domain (RBD)-ACE2 and SARS-CoV-2 RBD-ACE2 complexes. The study is published on the preprint server, bioRxiv*.

Recent advances in hardware and software allow molecular dynamics simulations on increasingly larger systems over longer timescales than were previously possible. These simulations produce large amounts of data, posing critical challenges for data analysis and interpretation. To tackle this, machine learning approaches were used to help identify residues that contribute the most to dynamical differences in the two viral RBDs.

SARS-CoV-2 S-protein binding to ACE2. (a) S-protein trimer (green, yellow, red) bound to the peptidase domain of ACE2 (blue). The lighter and darker shades of the trimer are S1 and S2, respectively. The viral envelope would be at the top and the host cell membrane at the bottom. (b) Close-up of the RBM (orange) interacting with ACE2. Residues near the interface are shown in a stick representation, colored by residue type (blue and red are positively and negatively charged, respectively, green is polar, white is hydrophobic). Specific residues in SARS-CoV-2 are labeled. (c) Alignment of the RBMs of SARS-CoV-2 and SARS-CoV19. Identical residues are white on red background.
SARS-CoV-2 S-protein binding to ACE2. (a) S-protein trimer (green, yellow, red) bound to the peptidase domain of ACE2 (blue). The lighter and darker shades of the trimer are S1 and S2, respectively. The viral envelope would be at the top and the host cell membrane at the bottom. (b) Close-up of the RBM (orange) interacting with ACE2. Residues near the interface are shown in a stick representation, colored by residue type (blue and red are positively and negatively charged, respectively, green is polar, white is hydrophobic). Specific residues in SARS-CoV-2 are labeled. (c) Alignment of the RBMs of SARS-CoV-2 and SARS-CoV19. Identical residues are white on red background.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Machine learning approaches accurately identified the most meaningful mutations for subsequent FEP calculations

The researchers used molecular dynamic simulations, machine learning, and free energy perturbation (FEP) calculations to illustrate differences in RBD binding by the two viruses. Although they observed only subtle differences from the initial molecular dynamic simulations of the 2 RBD-ACE2 complexes, machine learning identified the individual residues with distinctive ACE2 interactions, many of which were already highlighted by previous studies.

Essential dynamics analysis of two RBD-ACE2 complexes of SARS-CoV-2 and SARS-CoV viruses. (a) Eigenvalues and (b) fractional variance of top-10 modes. Three dominant modes of the complexes with (c) SARS-CoV-2 and (d) SARS-CoV. ACE2 and RBD are shown in blue and yellow, respectively. Motion of a loop in SARS-CoV in mode #2 is highlighted with a black oval.
Essential dynamics analysis of two RBD-ACE2 complexes of SARS-CoV-2 and SARS-CoV viruses. (a) Eigenvalues and (b) fractional variance of top-10 modes. Three dominant modes of the complexes with (c) SARS-CoV-2 and (d) SARS-CoV. ACE2 and RBD are shown in blue and yellow, respectively. Motion of a loop in SARS-CoV in mode #2 is highlighted with a black oval.

FEP calculations measured the corresponding differences in binding free energies to ACE2, and analysis of MD trajectories offered structural explanations for these observed differences. The energetics of emerging SARS-CoV-2 mutations were also studied, and it showed that the RBD’s affinity for ACE2 is increased by the N501Y and E484K mutations and slightly decreased by the K417N mutation.

“Significant differences in free energies (>1 kcal/mol) were observed for five of the seven mutations selected by our ML approaches, indicating that they accurately identified the most meaningful mutations for subsequent FEP calculations.”

The study demonstrates the utility of machine learning approaches in analyzing long MD trajectories

According to the authors, the study results suggest that the effects on ACE2 binding play a significant role in the natural selection of mutations in the RBD of SARS-CoV-2. Also, the mutations that affect ACE2 binding are not likely to become widespread. This work demonstrates the utility of machine learning approaches in analyzing long MD trajectories that could be readily generalized to other complexes.

“Our FEP results are in agreement with deep mutational scanning experiments by Star et al. as well as other experimental assays, demonstrating that our approach is a fast, accurate way to predict the effect of emerging SARS-CoV-2 mutations in the RBD.”

Snapshots from our MD simulations that illustrate the difference in ACE2 binding between SARS-CoV and SARS-CoV-2 for the selected mutations. ACE2 and RBD backbones are shown in blue and yellow, respectively. (a) Arg403/Lys390 (SARS-CoV-2/SARS-CoV numbering). (b) Lys417/Val404. (c) Asn439/Arg426. (d) Leu455/Tyr442. (e) Gln498-Asn501/Tyr484-Thr487. (f) Tyr491/Tyr505.
Snapshots from our MD simulations that illustrate the difference in ACE2 binding between SARS-CoV and SARS-CoV-2 for the selected mutations. ACE2 and RBD backbones are shown in blue and yellow, respectively. (a) Arg403/Lys390 (SARS-CoV-2/SARS-CoV numbering). (b) Lys417/Val404. (c) Asn439/Arg426. (d) Leu455/Tyr442. (e) Gln498-Asn501/Tyr484-Thr487. (f) Tyr491/Tyr505.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • Apr 6 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Susha Cheriyedath

Written by

Susha Cheriyedath

Susha is a scientific communication professional holding a Master's degree in Biochemistry, with expertise in Microbiology, Physiology, Biotechnology, and Nutrition. After a two-year tenure as a lecturer from 2000 to 2002, where she mentored undergraduates studying Biochemistry, she transitioned into editorial roles within scientific publishing. She has accumulated nearly two decades of experience in medical communication, assuming diverse roles in research, writing, editing, and editorial management.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Cheriyedath, Susha. (2023, April 06). Ai helps identify critical interactions for SARS-CoV-2 spike protein binding to ACE2. News-Medical. Retrieved on April 25, 2024 from https://www.news-medical.net/news/20210323/Ai-helps-identify-critical-interactions-for-SARS-CoV-2-spike-protein-binding-to-ACE2.aspx.

  • MLA

    Cheriyedath, Susha. "Ai helps identify critical interactions for SARS-CoV-2 spike protein binding to ACE2". News-Medical. 25 April 2024. <https://www.news-medical.net/news/20210323/Ai-helps-identify-critical-interactions-for-SARS-CoV-2-spike-protein-binding-to-ACE2.aspx>.

  • Chicago

    Cheriyedath, Susha. "Ai helps identify critical interactions for SARS-CoV-2 spike protein binding to ACE2". News-Medical. https://www.news-medical.net/news/20210323/Ai-helps-identify-critical-interactions-for-SARS-CoV-2-spike-protein-binding-to-ACE2.aspx. (accessed April 25, 2024).

  • Harvard

    Cheriyedath, Susha. 2023. Ai helps identify critical interactions for SARS-CoV-2 spike protein binding to ACE2. News-Medical, viewed 25 April 2024, https://www.news-medical.net/news/20210323/Ai-helps-identify-critical-interactions-for-SARS-CoV-2-spike-protein-binding-to-ACE2.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New tARC-seq method enhances precision in tracking SARS-CoV-2 mutations